Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment

Why did Moody’s downgrade US credit rating? How will tariffs impact US and European economy? What caused 23andMe bankruptcy and acquisition? Why is Nvidia expanding AI infrastructure in Taiwan? How will Capital One’s Discover acquisition affect customers? What’s behind the comeback of SPAC deals? Why did CBS News CEO resign amid Trump lawsuit? How are mortgage rates reacting to US credit downgrade? What’s driving recent volatility in Bitcoin and crypto?

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment

benzinga.com/25/05/45496095/novavax-scores-key-fda-win-shares-jump-19-as-sanofi-milestone-unlock

Novavax Inc. (NASDAQ:NVAX) has received limited approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Nuvaxovid, marking a regulatory milestone and unlocking a $175 million milestone payment from partner Sanofi SA (NASDAQ:SNY).
The protein-based vaccine, distinct…

This story appeared on benzinga.com, 2025-05-19 14:35:39.